Ki‐67 expression and BrdUrd incorporation as markers of proliferative activity in human prostate tumour models

Cell Proliferation

Volumn 26, Issue 1, 1993, Pages 67-75

  Van Weerden, W M ^a   Moerings, E P C M ^a   Kreuningen, A van ^a   De Jong, F H ^b   Van Steenbrugge, G J ^a   Schroder F H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; MONOCLONAL ANTIBODY KI 67; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CANCER TRANSPLANTATION; CELL PROLIFERATION; DNA SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PROSTATE TUMOR; TUMOR GROWTH; TUMOR VOLUME;

ANIMAL; BROMODEOXYURIDINE; CELL DIVISION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN; KI-67 ANTIGEN; MALE; MICE; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROSTATIC NEOPLASMS; STANOLONE; SUPPORT, NON-U.S. GOV'T; TESTOSTERONE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0027475119     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.1993.tb00007.x     Document Type: Article

References (38)

1. Monoclonal antibody Ki‐67: its use in histopathology
2. Assignment of the human Ki‐67 gene (MKI67) to 10q25‐qter
3. Determination of the proliferative fraction of a transplantable hormone‐dependent, human prostatic carcinoma (PC‐82) by monoclonal antibody Ki‐67: potential application for hormone therapy monitoring
4. Monoclonal antibody Ki‐67 defined growth fraction in benign prostatic hyperplasia and prostatic cancer
5. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation
6. Cell cycle analysis of a cell proliferation‐associated human nuclear antigen defined by the monoclonal antibody Ki‐67
7. Rapid and reliable separation of 5 alpha‐dihydro‐testosterone from testosterone on silica gel microcolumns
8. Human prostatic adenocarcinoma: some characteristics of a serially transplantable line in nude mice (PC‐82)
9. Prostatic adenocarcinoma PC‐EW, a new human tumour line transplantable in nude mice
10. Thymidine labelling index and Ki‐67 growth fraction in lesions of the breast
11. Flow cytometric multiparameter analysis of proliferating cell nuclear antigen/cyclin and Ki‐67 antigen: a new view of the cell cycle
12. Kinetic aspects of Ki‐67 antigen expression in a normal cell line
13. Flow cytometry, cellular DNA content, and prognosis in human malignancy
14. Proliferative activity of benign human prostate, prostatic adenocarcinoma and seminal vesicle evaluated by thymidine labelling
15. Simultaneous immunohistochemical detection of IUdR and BrdUrd infused intravenously to cancer patients
16. Immunocytochemical demonstration of S phase cells by anti‐bromodeoxyuridine monoclonal antibody in human prostate adenocarcinoma
17. Application of the monoclonal antibody Ki‐67 on prostate biopsies to assess the proliferative cell fraction of human prostatic carcinoma
18. Tumour proliferative fraction in solid malignant neoplasms
19. The cell cycle associated change of the Ki‐67 reactive nuclear antigen expression
20. Relationship between labeling indices of Ki‐67 and BrdUrd in human malignant tumours
21. Studies with anti‐bromodeoxyuridine antibodies. II. Simultaneous immunocytochemical detection of antigen expression and DNA synthesis by in vivo labeling of mouse intestinal mucosa
22. Basis of endocrine management of human prostatic carcinoma
23. Cell kinetics by bromodeoxyuridine labeling and deoxyribonucleic acid ploidy in prostatic carcinoma needle biopsies
24. Determination of subcutaneous tumour size in athymic (nude) mice
25. AgNOR area in interphase nuclei of human tumours correlates with the proliferative activity evaluated by bromodeoxyuridine labelling and Ki‐67 immunostaining
26. Cell proliferation of human bladder tumours determined by BrdUrd and Ki‐67 immunostaining
27. Nuclear distribution of the Ki‐67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells
28. Cell‐cycle‐related staining patterns of anti‐proliferating cell nuclear antigen monoclonal antibodies
29. The use of steroid‐containing Silastic implants in male nude mice: plasma hormone levels and the effect of implantation on the weights of the ventral prostate and seminal vesicles
30. Biological effects of hormonal treatment regimens on a transplantable human prostatic tumor line (PC‐82)
31. Effects of low testosterone levels and of adrenal androgens on growth of prostate tumour models in nude mice
32. Assessment of the critical level of androgen for growth response of transplantable human prostatic carcinoma (PC‐82) in nude mice
33. Castration‐induced changes in androgen levels and proliferative activity of human prostate cancer tissue grown in athymic nude mice
34. 3[H]‐thymidine labelling index and monoclonal antibody Ki‐67 in non‐Hodgkin's lymphomas
35. Evaluation of a radioimmu‐noassay for testosterone estimation
36. Long‐term storage of samples for flow cytometric DNA analysis
37. A detergent‐trypsin method for the preparation of nuclei for flow cytometric DNA analysis
38. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry